Long-acting injectable antipsychotics provide better outcomes in bipolar disorder and older schizophrenia patients

A probe squad from the Department of Pharmacology and Pharmacy astatine the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has recovered that long-acting injectable (LAI) antipsychotics supply amended attraction outcomes than oral antipsychotic medications for patients 65 and older with schizophrenia.